搜尋結果
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 6 日前A recent study in the New England Journal of Medicine grabbed the attention of the medical ...
Bcl-2抑制劑APG-2575治療AML患者數據更新 聯合AZA療效和安全性良好
阿思達克財經網· 19 小時前亞盛醫藥(06855)今日宣佈,公司已在第60屆美國臨牀腫瘤學會(ASCO)年會上,以壁報展示形式公佈了Bcl-2抑...
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters· 2 日前, opens new tab multiple myeloma drug Blenrep nearly halved the risk of disease progression or ...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters· 5 日前, opens new tab said on Thursday the U.S. FDA had allowed expanded use of its cell therapy for ...
GSK’s Withdrawn Blood Cancer Drug Poised for Comeback
Bloomberg· 2 日前GSK Plc said a blood cancer drug it had to pull from the market after a trial failure has shown ...